A Multiple Myeloma specialist is a cancer doctor who has experience in diagnosing and treating cancers that develop from plasma cells in the bone marrow. These doctors are generally medical oncologists or haematologists with expertise in blood cancers and plasma cell disorders.

Multiple Myeloma is different from many solid-organ cancers because it develops inside the bone marrow. It can affect the production of normal blood cells and cause complications involving the bones, kidneys and immune system.

A specialist evaluates the complete medical condition rather than focusing only on the cancer cells. This includes understanding blood test reports, bone marrow biopsy results, imaging findings and the patient's overall health.

If you are searching for a Best Multiple Myeloma Doctor in South Mumbai, it is important to consider the doctor's medical qualifications, experience in treating blood cancers, understanding of newer treatment approaches and ability to guide patients through different stages of care.

Dr. Reetu Jain, a Medical Oncologist and BMT Physician, offers specialist guidance for patients dealing with blood cancers. Her approach involves understanding each patient's medical reports and discussing appropriate treatment and supportive care options.

As these cancerous cells increase, they can affect the normal functioning of the bone marrow. This may reduce the production of healthy red blood cells, white blood cells and platelets.

Multiple Myeloma can also cause damage to the bones, increase calcium levels in the blood and affect kidney function.

The condition may develop gradually, and some patients may not experience noticeable symptoms during the early stages. In certain cases, it is discovered during routine blood investigations.

Multiple Myeloma is also known as plasma cell myeloma. It requires specialised evaluation and long-term medical management.

If you are searching for a Blood Cancer Doctor in South Mumbai, understanding the condition and getting the right medical advice are important steps towards appropriate care.

The exact cause of Multiple Myeloma is not completely understood. The condition develops when plasma cells undergo changes that cause them to grow and multiply abnormally.

These abnormal cells gradually accumulate in the bone marrow and interfere with normal blood cell production.

Certain factors may be associated with an increased risk of developing Multiple Myeloma. These include:

• Increasing age: Multiple Myeloma is more commonly diagnosed in older adults.
• Family history: Having a close family member with Multiple Myeloma may be associated with a higher risk.
• Certain plasma cell conditions: Some people with Monoclonal Gammopathy of Undetermined Significance (MGUS) or smouldering Multiple Myeloma may develop active disease over time.
• Certain environmental and occupational exposures: Some exposures have been studied for possible associations with the disease, although the exact relationship is not fully established.

Having one or more risk factors does not mean that someone will definitely develop Multiple Myeloma. Many patients have no clearly identifiable risk factors.

A consultation with a Medical Oncologist can help patients understand their medical history, risk factors and the investigations required for diagnosis.

Multiple Myeloma does not progress in exactly the same way in every patient. Some patients have slow-growing disease, while others may require treatment soon after diagnosis.
Understanding the disease category is important for deciding the appropriate medical approach.

• 1. MGUS (Monoclonal Gammopathy of Undetermined Significance):MGUS is a condition in which abnormal monoclonal proteins are present in the blood, but the patient does not meet the criteria for Multiple Myeloma or have related organ damage.
  MGUS is not Multiple Myeloma. However, patients generally require periodic medical monitoring because a small proportion may develop a more advanced plasma cell disorder over time.
• 2. Smouldering Multiple Myeloma: Smouldering Multiple Myeloma is an intermediate condition in which abnormal plasma cells or monoclonal proteins are present at higher levels than in MGUS, but there are no defining signs of active Multiple Myeloma requiring treatment.
  Patients with this condition may not need immediate treatment. However, regular follow-up and monitoring are important to identify any signs of progression.
• 3. Active Multiple Myeloma: Active Multiple Myeloma is diagnosed when the patient meets the established diagnostic criteria, including relevant biomarkers or evidence of organ damage associated with the disease.
  Treatment is generally recommended when active disease meets the criteria for therapy.
  A specialist evaluates the patient's reports to determine the disease category and whether treatment or regular monitoring is appropriate.

Bone marrow or stem cell transplantation can play an important role in the management of Multiple Myeloma for eligible patients.

Autologous stem cell transplantation is the commonly used transplant approach for selected patients. It involves collecting the patient's own stem cells before administering high-dose chemotherapy.

After chemotherapy, the collected stem cells are returned to the patient's bloodstream. These cells travel to the bone marrow and help restore the production of healthy blood cells.

The procedure is not suitable for everyone. Doctors consider several factors before recommending transplantation, including:

• The patient's age and physical fitness.
• Kidney, heart and lung function.
• Response to initial treatment.
• Disease stage and genetic risk.
• Other existing medical conditions.

Stem cell transplantation is generally considered as part of a broader treatment strategy rather than a standalone procedure.

Dr. Reetu Jain's background in Medical Oncology and Bone Marrow Transplantation is relevant for patients seeking guidance about different blood cancer treatment approaches.

Patients searching for a Blood Cancer Specialist in South Mumbai can discuss whether stem cell transplantation may be an appropriate option based on their reports and medical condition.

Multiple Myeloma treatment can cause side effects, although their nature and severity vary between patients.

Some patients experience mild symptoms, while others may require additional medical support during treatment.

Common treatment-related concerns include:

• Fatigue and weakness.
• Nausea or vomiting.
• Reduced appetite.
• Increased risk of infections.
• Nerve-related symptoms such as tingling or numbness.
• Changes in blood cell counts.
• Constipation or diarrhoea.
• Changes in kidney function.

Managing these effects is an important part of cancer care.

The treating doctor may recommend medicines, dietary guidance, infection prevention measures, blood investigations or changes in treatment schedules depending on the patient's needs.

Fever during cancer treatment, sudden severe weakness, new breathing difficulties or other serious symptoms require prompt medical attention.